FruitVaccine Family
|
S. Indu Rupassara, PhD, MBA (Co-Founder/President/CEO)
|
The Late Dennis E. Buetow, PhD (Co-Founder/Founding President)
|
|
John W. Kindt Jr., MBA, BS (Technical & Business Analyst)
|
Claire P. Schane, BS (Research
Assistant) 
|
Dawson Dodds, BS (Supply Chain & Marketing Assistant)
|
Emily Sandoval, BS (Healthcare Planning Assistant)
|
Research Advisors/Consultants/Collaborators
|
Charles J. Arntzen, Ph.D.
|
M. Kathleen Buetow, MD, DrPH
|
Edwin G. Moore, Ph.D.
|
Brenda Anne Wilson, Ph.D.
|
|
Hugh S. Mason, Ph.D.
|
Erik Nelson,
Ph.D. 
|
Indika Kahanda, Ph.D.
|
Jagdeep S. Sandhu, Ph.D.
|
|
Jose O. Solbiati, Ph.D.
|
Daniel McKim,
Ph.D. 
|
Robert Carnahan, Ph.D.
|
Other Consultants
Marketing - Nancy Sullivan
|
Budgeting - Roland Garton
|
Legal - Alan Singleton
|
Strategy - Dennis Beard
|
Technical Support Professionals
Xanthe Brown
Communicator
Management of FVI Facebook page and Youtube channel, FVI video-editing |
Haidong Wang
Data Analyst/Statistician
Assists in Customer Discoveries and related data analysis |
Aigerim Kamzina
Research Associate
Preparation of gene constructs and conducting related lab research |
Mike Thomas
Artist/Videographer
Adding artistic touches/edits to FVI graphics and videos |
Alan Noegroho
Finance Strategist
Researching the funding strategies and management of FVI LinkedIn page |
Mia Takekawa
Research Assistant
Assisting in lab and greenhouse research |
Allen Ni
Technical Strategist
Assists in developing the FVI business strategy and technical plans |
Aaksa Nair
Data Analyst
Data analysis and FVI business ecosystem development assistance |
Mingze Xiao
Programmer
Website development |
Carol Wei
Auditor
Initiation of FVI Facebook and LinkedIn pages |
Matt Thomas
Organizational Developer
Assists in strategizing organizational development |
Extended Biographies
S. Indu Rupassara, PhD, MBA (Co-Founder/President/CEO)
Dr. Rupassara’s multidisciplinary research and managerial expertise includes biotechnology, microbiology, immunology, biochemistry, and ‘omics’ technologies, using a wide array of biological systems such as humans, small model animals, plants, and microorganisms. Indu has presented talks in conferences in the US, Europe, Australia, and Asia as a Researcher and an Entrepreneur. Indu received her PhD (Metabolomics/Biotechnology), Professional-MBA, and MS (Biochemistry) degrees from the University of Illinois at Urbana-Champaign, USA (UIUC), MSc (Microbiology) from the University of Sydney, Australia, and BSc (Agric. Sc.) from the University of Peradeniya, Sri Lanka.
LinkedIn and Google Scholar
Dr. Rupassara’s multidisciplinary research and managerial expertise includes biotechnology, microbiology, immunology, biochemistry, and ‘omics’ technologies, using a wide array of biological systems such as humans, small model animals, plants, and microorganisms. Indu has presented talks in conferences in the US, Europe, Australia, and Asia as a Researcher and an Entrepreneur. Indu received her PhD (Metabolomics/Biotechnology), Professional-MBA, and MS (Biochemistry) degrees from the University of Illinois at Urbana-Champaign, USA (UIUC), MSc (Microbiology) from the University of Sydney, Australia, and BSc (Agric. Sc.) from the University of Peradeniya, Sri Lanka.
LinkedIn and Google Scholar
The Late Dennis E. Buetow, PhD (Co-Founder/Founding President)
Dr. Buetow served at the National Institutes of Health (NIH) and at Baltimore City Hospitals in Maryland from 1959 to 1965. Since 1965, he was employed as a Professor in the Department of Molecular and Integrative Physiology at UIUC. He was Head of this department from 1983-1988 and Interim Head from 1991-1992. He was Professor Emeritus in this department where he did research on a daily basis. He received his PhD in 1959 from the University of California, Los Angeles (UCLA). He was Editor for the Academic Press series “Cell Biology, a Series of Monographs” among over 100 other book chapters and journal articles on his research. Dennis is missed dearly by all of us at FruitVaccine and we will strive to carry on the vision he helped to create.
LinkedIn and Google Scholar
Dr. Buetow served at the National Institutes of Health (NIH) and at Baltimore City Hospitals in Maryland from 1959 to 1965. Since 1965, he was employed as a Professor in the Department of Molecular and Integrative Physiology at UIUC. He was Head of this department from 1983-1988 and Interim Head from 1991-1992. He was Professor Emeritus in this department where he did research on a daily basis. He received his PhD in 1959 from the University of California, Los Angeles (UCLA). He was Editor for the Academic Press series “Cell Biology, a Series of Monographs” among over 100 other book chapters and journal articles on his research. Dennis is missed dearly by all of us at FruitVaccine and we will strive to carry on the vision he helped to create.
LinkedIn and Google Scholar
John W. Kindt Jr., MBA, BS (Technical & Business Analyst)
John Kindt serves as a business and technical specialist with a decade of experience in the financial services industry and University of Illinois at Urbana Champaign (UIUC) system. He is working with Dr. Rupassara assisting FruitVaccine’s R&D efforts through data analysis, forecasting, and funding applications, and evaluating the feasibility of novel processes and production methods. John also performs market analysis and helps manage the development of a unique logistic FruitVaccine ecosystem. John received his MBA from the Gies College of Business at UIUC, and his BS degree in Finance from Eastern Illinois University.
John Kindt serves as a business and technical specialist with a decade of experience in the financial services industry and University of Illinois at Urbana Champaign (UIUC) system. He is working with Dr. Rupassara assisting FruitVaccine’s R&D efforts through data analysis, forecasting, and funding applications, and evaluating the feasibility of novel processes and production methods. John also performs market analysis and helps manage the development of a unique logistic FruitVaccine ecosystem. John received his MBA from the Gies College of Business at UIUC, and his BS degree in Finance from Eastern Illinois University.
Claire P. Schane, BS (Research Assistant)
Claire Schane is a researcher who obtained her Bachelors of Science in Chemistry from UIUC. While pursuing her undergraduate education, Claire gained research experience in Food Science and Immunology. After her graduation, she began working as a full-time researcher in Biochemistry and Immunology in the areas of cancer therapy and protein-engineering. Claire began working with Dr. Rupassara on grant proposals and funding opportunities in February 2019. She now will use her laboratory experience along with her understanding and dedication to FruitVaccine towards the vaccine development projects in the company.
Claire Schane is a researcher who obtained her Bachelors of Science in Chemistry from UIUC. While pursuing her undergraduate education, Claire gained research experience in Food Science and Immunology. After her graduation, she began working as a full-time researcher in Biochemistry and Immunology in the areas of cancer therapy and protein-engineering. Claire began working with Dr. Rupassara on grant proposals and funding opportunities in February 2019. She now will use her laboratory experience along with her understanding and dedication to FruitVaccine towards the vaccine development projects in the company.
Dawson Dodds, BS (Supply Chain & Marketing Assistant)
Dawson Dodds is a supply chain and business professional with Bachelors of Science in Finance and in Supply Chain Management from UIUC. Throughout his time at UIUC and post-graduation, he has had experience with contracting and procurement, social enterprise consulting, onboarding, data mining, and volunteer outreach. Dawson joined the FruitVaccine family in 2019 and has been working with Dr. Rupassara employing his breadth of experience for developing cost models and future business plans, marketing materials, and designing the FV website. He has a passion for biotechnology and is excited for the future of the company.
Dawson Dodds is a supply chain and business professional with Bachelors of Science in Finance and in Supply Chain Management from UIUC. Throughout his time at UIUC and post-graduation, he has had experience with contracting and procurement, social enterprise consulting, onboarding, data mining, and volunteer outreach. Dawson joined the FruitVaccine family in 2019 and has been working with Dr. Rupassara employing his breadth of experience for developing cost models and future business plans, marketing materials, and designing the FV website. He has a passion for biotechnology and is excited for the future of the company.
Emily Sandoval, BS (Healthcare Planning Assistant)
Emily Sandoval is a researcher who obtained her Bachelors of Science in Community Health with a concentration in Health Administration from the University of Illinois Urbana-Champaign. Emily gained work experience at Carle Foundation Hospital in the surgical services department and at Rush University Medical Center. She has been working with Dr. Rupassara since February 2019 managing projects aimed to increase hRSV awareness on FruitVaccine's Twitter and Instagram pages, and compiling publication findings on respiratory viruses impacting us across the globe.
Emily Sandoval is a researcher who obtained her Bachelors of Science in Community Health with a concentration in Health Administration from the University of Illinois Urbana-Champaign. Emily gained work experience at Carle Foundation Hospital in the surgical services department and at Rush University Medical Center. She has been working with Dr. Rupassara since February 2019 managing projects aimed to increase hRSV awareness on FruitVaccine's Twitter and Instagram pages, and compiling publication findings on respiratory viruses impacting us across the globe.
Charles J. Arntzen, Ph.D.
Dr. Arntzen is an elected member of the U.S. National Academy of Sciences and the National Academy of Inventors. He received the USDA Award for Superior Service, and served as chairman of the National Biotechnology Policy Board of the National Institutes of Health. Dr. Arntzen’s primary research interests have been in plant molecular biology and protein engineering, as well as the utilization of plant biotechnology for enhancement of food quality and value, and for expression of pharmacologically active products in transgenic plants. He has been recognized as a pioneer in the development of plant-based vaccines for human disease prevention, and for disease prevention in animal agriculture.
More about Charles
Dr. Arntzen is an elected member of the U.S. National Academy of Sciences and the National Academy of Inventors. He received the USDA Award for Superior Service, and served as chairman of the National Biotechnology Policy Board of the National Institutes of Health. Dr. Arntzen’s primary research interests have been in plant molecular biology and protein engineering, as well as the utilization of plant biotechnology for enhancement of food quality and value, and for expression of pharmacologically active products in transgenic plants. He has been recognized as a pioneer in the development of plant-based vaccines for human disease prevention, and for disease prevention in animal agriculture.
More about Charles
M. Kathleen Buetow, MD, DrPH
Dr. Buetow had been a Pediatric Physician on the staff of Carle Foundation Hospital and a member of the Carle Physician Group in Urbana, Illinois during 1965-2020. She served on Carle’s Immunization Committee as the Head of the Department of Pediatrics at the University of Illinois College of Medicine at UIUC from 1986-2007. Kathleen received an MD from the University of Maryland in 1954 and a Doctor of Public Health degree at Johns Hopkins School of Hygiene and Public Health. She became a diplomat of the American Academy of Pediatrics (AAP) in 1959, and has been a member of the AAP since then.
More about Kathleen
Dr. Buetow had been a Pediatric Physician on the staff of Carle Foundation Hospital and a member of the Carle Physician Group in Urbana, Illinois during 1965-2020. She served on Carle’s Immunization Committee as the Head of the Department of Pediatrics at the University of Illinois College of Medicine at UIUC from 1986-2007. Kathleen received an MD from the University of Maryland in 1954 and a Doctor of Public Health degree at Johns Hopkins School of Hygiene and Public Health. She became a diplomat of the American Academy of Pediatrics (AAP) in 1959, and has been a member of the AAP since then.
More about Kathleen
Edwin G. Moore, Ph.D.
Dr. Moore brings 30 years of biopharmaceutical, pharmaceutical, and clinical diagnostic industry experience from global companies, Baxter Healthcare Corp and Abbott Laboratories, in R&D product development. He has held various roles in CMC pre-clinical product development for recombinant therapeutic proteins and for IV parenteral small molecule products in Analytical Method Development, Stability Testing, Formulation, as well as leading overall pre-clinical product development for a recombinant therapeutic protein product. Ed also mentors start-up companies at EnterpriseWorks, the University of Illinois Business incubator. Ed has a PhD in Physical Biochemistry from Cornell University, NY, and received a BS from UIUC.
More about Ed
Dr. Moore brings 30 years of biopharmaceutical, pharmaceutical, and clinical diagnostic industry experience from global companies, Baxter Healthcare Corp and Abbott Laboratories, in R&D product development. He has held various roles in CMC pre-clinical product development for recombinant therapeutic proteins and for IV parenteral small molecule products in Analytical Method Development, Stability Testing, Formulation, as well as leading overall pre-clinical product development for a recombinant therapeutic protein product. Ed also mentors start-up companies at EnterpriseWorks, the University of Illinois Business incubator. Ed has a PhD in Physical Biochemistry from Cornell University, NY, and received a BS from UIUC.
More about Ed
Brenda Anne Wilson, Ph.D.
Dr. Wilson is a Professor of Microbiology and Assoc. Director of Undergraduate Education in the School of Molecular & Cellular Biology, with a joint appointment in Pathobiology, College of Vet. Med., at UIUC. She is also an Inaugural Professor in the Carle Illinois College of Medicine. Her current research focuses on host-microbe interactions: bacterial protein toxins and their molecular interactions with eukaryotic hosts; developing novel post-exposure antitoxin therapeutics and delivery platforms; and drug resistant microbes in health and disease. Dr. Wilson earned her B.A. from Columbia University, NY, and her M.S.-Ph.D. degrees (in Chemistry: β-lactam antibiotics) from the Johns Hopkins University, MD. Her PostDoc at Harvard Medical School was on bacterial protein toxins.
More about Brenda
Dr. Wilson is a Professor of Microbiology and Assoc. Director of Undergraduate Education in the School of Molecular & Cellular Biology, with a joint appointment in Pathobiology, College of Vet. Med., at UIUC. She is also an Inaugural Professor in the Carle Illinois College of Medicine. Her current research focuses on host-microbe interactions: bacterial protein toxins and their molecular interactions with eukaryotic hosts; developing novel post-exposure antitoxin therapeutics and delivery platforms; and drug resistant microbes in health and disease. Dr. Wilson earned her B.A. from Columbia University, NY, and her M.S.-Ph.D. degrees (in Chemistry: β-lactam antibiotics) from the Johns Hopkins University, MD. Her PostDoc at Harvard Medical School was on bacterial protein toxins.
More about Brenda
Hugh S. Mason, Ph.D.
Dr. Mason, an Associate Professor at Arizona State University, was the first to publish peer-reviewed work on the use of plants for production of vaccine antigens, showing expression of authentic hepatitis B surface antigen in tobacco (Mason et al., 1992). He was a leader in this field for many years and continues to publish work in plant-based vaccines (Kim et al., 2015). With funding from NIH-NIAID, Dr. Mason focused on oral delivery of vaccines for enteric diseases including Norwalk virus (Mason et al., 1996) and enterotoxic E. coli (Haq et al., 1995), and demonstrated oral immunogenicity in mice after ingestion of transgenic potato tuber.
More about Hugh
Dr. Mason, an Associate Professor at Arizona State University, was the first to publish peer-reviewed work on the use of plants for production of vaccine antigens, showing expression of authentic hepatitis B surface antigen in tobacco (Mason et al., 1992). He was a leader in this field for many years and continues to publish work in plant-based vaccines (Kim et al., 2015). With funding from NIH-NIAID, Dr. Mason focused on oral delivery of vaccines for enteric diseases including Norwalk virus (Mason et al., 1996) and enterotoxic E. coli (Haq et al., 1995), and demonstrated oral immunogenicity in mice after ingestion of transgenic potato tuber.
More about Hugh
Erik Nelson, Ph.D.
Dr. Nelson is an Associate Professor of Molecular and Integrative Physiology at UIUC. He received his BSc (major: zoology, minor: chemistry) and PhD in comparative endocrinology from the University of Calgary. His PostDoc at Duke University was in pharmacology and cancer biology, prior to joining UIUC faculty. Dr. Nelson's research program is focused on how hormones and cholesterol metabolism impact breast and ovarian cancer progression. In recognition of his research, Dr. Nelson has been awarded the Government of Alberta Queen Elizabeth II Graduate Scholarship, a Department of Defense Breast Cancer Research Program Postdoctoral Fellowship Award, and a National Cancer Institute Pathway to Independence Award.
More about Erik
Dr. Nelson is an Associate Professor of Molecular and Integrative Physiology at UIUC. He received his BSc (major: zoology, minor: chemistry) and PhD in comparative endocrinology from the University of Calgary. His PostDoc at Duke University was in pharmacology and cancer biology, prior to joining UIUC faculty. Dr. Nelson's research program is focused on how hormones and cholesterol metabolism impact breast and ovarian cancer progression. In recognition of his research, Dr. Nelson has been awarded the Government of Alberta Queen Elizabeth II Graduate Scholarship, a Department of Defense Breast Cancer Research Program Postdoctoral Fellowship Award, and a National Cancer Institute Pathway to Independence Award.
More about Erik
Indika Kahanda, Ph.D.
Dr. Indika Kahanda is an Assistant Professor in the School of Computing at the University of North Florida, where he directs the bioinformatics, biomedical informatics, and medical informatics lab. His research interests lie in the areas of Bioinformatics, Biomedical Informatics, and Medical Informatics. He focuses on the application of machine learning and natural language processing techniques to solve problems involving large-scale biological, molecular, and biomedical data. He received his Ph.D. in Computer Science from Colorado State University in 2016 in the area of Bioinformatics, a Master of Science in Computer Engineering from Purdue University in 2010, and a Bachelor of Science in Computer Engineering from University of Peradeniya, Sri Lanka in 2007.
More about Indika
Dr. Indika Kahanda is an Assistant Professor in the School of Computing at the University of North Florida, where he directs the bioinformatics, biomedical informatics, and medical informatics lab. His research interests lie in the areas of Bioinformatics, Biomedical Informatics, and Medical Informatics. He focuses on the application of machine learning and natural language processing techniques to solve problems involving large-scale biological, molecular, and biomedical data. He received his Ph.D. in Computer Science from Colorado State University in 2016 in the area of Bioinformatics, a Master of Science in Computer Engineering from Purdue University in 2010, and a Bachelor of Science in Computer Engineering from University of Peradeniya, Sri Lanka in 2007.
More about Indika
Jagdeep S. Sandhu, Ph.D.
Dr. Sandhu obtained his PhD from the University of Cambridge, UK, in 1996. He conducted postgraduate research on transfer of the RSV fusion-protein into plants, at the University of Illinois at Urbana-Champaign (1996-2000, in Buetow-lab), and then as a biotechnologist at the Punjab Agricultural University, India, where he is employed at the present time.
More about Jagdeep
Dr. Sandhu obtained his PhD from the University of Cambridge, UK, in 1996. He conducted postgraduate research on transfer of the RSV fusion-protein into plants, at the University of Illinois at Urbana-Champaign (1996-2000, in Buetow-lab), and then as a biotechnologist at the Punjab Agricultural University, India, where he is employed at the present time.
More about Jagdeep
Jose O. Solbiati, Ph.D.
Dr. Mason, an Associate Professor at Arizona State University, was the first to publish peer-reviewed work on the use of plants for production of vaccine antigens, showing expression of authentic hepatitis B surface antigen in tobacco (Mason et al., 1992). He was a leader in this field for many years and continues to publish work in plant-based vaccines (Kim et al., 2015). With funding from NIH-NIAID, Dr. Mason focused on oral delivery of vaccines for enteric diseases including Norwalk virus (Mason et al., 1996) and enterotoxic E. coli (Haq et al., 1995), and demonstrated oral immunogenicity in mice after ingestion of transgenic potato tuber.
More about Hugh
Dr. Mason, an Associate Professor at Arizona State University, was the first to publish peer-reviewed work on the use of plants for production of vaccine antigens, showing expression of authentic hepatitis B surface antigen in tobacco (Mason et al., 1992). He was a leader in this field for many years and continues to publish work in plant-based vaccines (Kim et al., 2015). With funding from NIH-NIAID, Dr. Mason focused on oral delivery of vaccines for enteric diseases including Norwalk virus (Mason et al., 1996) and enterotoxic E. coli (Haq et al., 1995), and demonstrated oral immunogenicity in mice after ingestion of transgenic potato tuber.
More about Hugh
Daniel McKim, Ph.D.
Dr. McKim is an assistant professor in the Department of Animal Science at UIUC. He completed his doctoral and postdoctoral training at The Ohio State University Wexner Medical Center with a focus on neuroendocrine regulation of hematopoiesis using mouse models. Dr. McKim currently runs a research lab studying the interactions between lifestyle factors, hematopoiesis, and chronic health conditions. Dr. McKim contributes to the FruitVaccine Team with his expertise in animal modeling for immunology research and employs relevant techniques including flow cytometry, single cell transcriptomics, and functional assays.
More about Daniel and profile
Dr. McKim is an assistant professor in the Department of Animal Science at UIUC. He completed his doctoral and postdoctoral training at The Ohio State University Wexner Medical Center with a focus on neuroendocrine regulation of hematopoiesis using mouse models. Dr. McKim currently runs a research lab studying the interactions between lifestyle factors, hematopoiesis, and chronic health conditions. Dr. McKim contributes to the FruitVaccine Team with his expertise in animal modeling for immunology research and employs relevant techniques including flow cytometry, single cell transcriptomics, and functional assays.
More about Daniel and profile
Robert Carnahan, Ph.D.
Dr. Robert Carnahan is an Associate Professor in Pediatrics and Associate Director of the Vanderbilt Vaccine Center at Vanderbilt University Medical Center. His expertise is in the discovery of novel antibody therapeutics and rapid pandemic response platforms. In particular, he has guided the DARPA-funded Pandemic Prevention Platform (P3) program at VUMC. The goal of this program was to define and test rapid response platforms for viral pandemics. This platform was activated to respond to SARS-CoV-2 in 2020 and developed a large panel of potential antibody therapeutics, some of which are now in Phase 3 clinical trials. Dr. Carnahan is also a recognized expert in Lean Laboratory management practices.
More about Robert and profile
Dr. Robert Carnahan is an Associate Professor in Pediatrics and Associate Director of the Vanderbilt Vaccine Center at Vanderbilt University Medical Center. His expertise is in the discovery of novel antibody therapeutics and rapid pandemic response platforms. In particular, he has guided the DARPA-funded Pandemic Prevention Platform (P3) program at VUMC. The goal of this program was to define and test rapid response platforms for viral pandemics. This platform was activated to respond to SARS-CoV-2 in 2020 and developed a large panel of potential antibody therapeutics, some of which are now in Phase 3 clinical trials. Dr. Carnahan is also a recognized expert in Lean Laboratory management practices.
More about Robert and profile